Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

Management of advanced hepatocellular carcinoma in the era of targeted therapy

(2010) Thomas Yau et al.   LIVER INTERNATIONAL

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

(2009) Salvatore Del Prete et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis

(2009) Jui-Chu Yang et al.   HEPATOLOGY

Vibrio vulnificus-induced Cell Death of Human Mononuclear Cells Requires ROS-dependent Activation of p38 and ERK 1/2 MAPKs

(2009) Woo Hyang Kim et al.   IMMUNOLOGICAL INVESTIGATIONS

Angiogenesis in liver disease

(2009) Mercedes Fernández et al.   JOURNAL OF HEPATOLOGY

Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated Control of Growth in Human Hepatocellular Carcinoma

(2008) D. F. Calvisi et al.   CANCER RESEARCH

Mechanisms of Action and Resistance of Somatostatin Analogues for the Treatment of Hepatocellular Carcinoma: A Message Not Well Taken

(2008) Dimitrios N. Samonakis et al.   DIGESTIVE DISEASES AND SCIENCES

Molecular mechanisms for discrete nitric oxide levels in cancer

(2008) Lisa A. Ridnour et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY